MSc Biotechnology and Business

1 Year On Campus Masters Program

University College Dublin

Program Overview

The MSc Biotherapeutics & Business at University College Dublin blends advanced scientific training in drug discovery and bioprocessing with a comprehensive business education, preparing graduates to lead in the biopharmaceutical industry. It suits science graduates who want to combine expertise in molecular biotechnology with skills in strategy, finance, and commercialization.

Curriculum Structure

Autumn Trimester
Students begin with a dual focus: scientific foundations and business principles. Modules such as Biotherapeutic Pipeline I and The Business of Biotechnology and Science introduce the discovery and development of biomolecular drug candidates while exploring commercialization challenges. Alongside, Marketing Management and Professional Career Development sharpen communication and leadership skills.

Spring Trimester
The second stage deepens both scientific and managerial expertise. Courses like Biotherapeutic Pipeline II and Systems Biology in Drug Development expand knowledge of antibody engineering and systems-level approaches to drug discovery. In parallel, Business Strategy, Organisational Behaviour, and Corporate Finance equip students with the tools to evaluate investments, manage teams, and design growth strategies.

Summer Trimester
The program culminates in applied projects. Through Feasibility and Business Plan and the Biotherapeutics Case Study, students integrate science and business by developing commercialization strategies for new drug entities. This stage emphasizes independent thinking, problem-solving, and applied research, ensuring graduates can bridge the gap between laboratory innovation and market success.

Focus Areas

Biotherapeutic drug discovery, antibody engineering, bioprocessing, commercialization strategy, corporate finance, marketing management, regulatory affairs.

Learning Outcomes

Graduates will:

Demonstrate comprehensive understanding of biotherapeutics development and business principles.
Apply knowledge to overcome commercialization challenges in biotech.
Conduct applied valuation studies of new drug entities.
Collaborate with scientists and entrepreneurs to develop innovative solutions.
Communicate research effectively and manage projects in professional settings.

Professional Alignment (Accreditation)

This NFQ Level 9 Master’s program is developed in consultation with employers and integrates a business development plan, ensuring graduates are recognized and valued by leading biopharma companies.

Reputation (Employability Rankings)

UCD is ranked among the top 1% of universities worldwide and consistently performs strongly in QS Graduate Employability Rankings. Employers such as Abbott, Allergan, Amgen, Baxter Healthcare, Eli Lilly, GSK, Janssen, MSD, and Johnson & Johnson actively recruit graduates from this program.

Experiential Learning (Research, Projects, Internships etc.)

One of the most exciting aspects of UCD’s MSc Biotherapeutics & Business is how it blends theory with practice. Students don’t just learn about drug discovery and commercialization in the classroom — they actively engage with laboratories, case studies, and business projects that mirror the challenges faced by global biopharma companies. The program is jointly delivered by the UCD School of Biomolecular and Biomedical Science and the UCD Michael Smurfit Graduate Business School, giving students access to both cutting‑edge scientific facilities and Ireland’s leading business education environment.

Here’s how experiential learning is built into the program:

Laboratory Training: Students gain hands‑on experience in mammalian cell culture and bioprocess laboratories, learning practical techniques in antibody engineering, biochemical characterization, and systems biology.
Case Studies & Group Projects: The Biotherapeutics Case Study module requires students to work in teams to evaluate real drug development pipelines, integrating scientific and business perspectives.
Business Plan Development: Through the Feasibility and Business Plan module, students design commercialization strategies for new drug entities, applying financial modeling and market analysis tools taught at Smurfit Business School.
Digital & Analytical Tools: Students use systems biology software and bioprocess modeling tools to simulate drug development processes, enhancing their ability to translate lab data into business insights.
Industry Exposure: Guest lectures and project collaborations with Ireland’s thriving biopharma sector provide direct insight into how companies like Pfizer, Amgen, and MSD operate.
Library & Research Resources: Access to UCD’s extensive scientific databases and Smurfit’s business library ensures students can research both the technical and commercial aspects of biotherapeutics.
Institute Connections: The program leverages UCD’s partnerships with institutes such as the National Institute for Bioprocessing Research and Training (NIBRT), offering students exposure to facilities that replicate real biopharmaceutical manufacturing environments.

Progression & Future Opportunities

Graduates of UCD’s MSc Biotherapeutics & Business are uniquely positioned to bridge the gap between science and industry. With expertise in drug discovery, bioprocessing, and commercialization, alumni typically progress into roles such as Regulatory Affairs Specialist, Business Development Manager, Bioprocess Scientist, and Clinical Research Associate. The program’s dual focus on biotechnology and business ensures graduates are highly employable across Ireland’s thriving biopharma sector and beyond:

Career Services: Students benefit from UCD’s Career Development Centre and the Smurfit Graduate Business School Career Service, which provide tailored workshops, employer networking events, and one‑to‑one coaching to secure interviews and career placements.
Employment Outcomes: UCD highlights strong graduate employability, with alumni securing positions in leading companies such as Abbott, Amgen, Baxter Healthcare, Eli Lilly, GSK, Janssen, MSD, and Johnson & Johnson.
Industry Partnerships: The program leverages UCD’s close ties with Ireland’s biopharma ecosystem, including collaborations with Pfizer, MSD, ICON plc, and NIBRT (National Institute for Bioprocessing Research and Training), ensuring students gain exposure to real industry challenges.
Accreditation Value: As a Level 9 NFQ Master’s qualification, the degree holds long‑term recognition both in Ireland and internationally, supporting career mobility across regulated biotech and pharmaceutical industries.
Graduate Outcomes: Alumni testimonials emphasize progression into regulatory affairs, business strategy roles, and research positions, demonstrating the program’s ability to open diverse career pathways.

Further Academic Progression:
After completing the MSc Biotherapeutics & Business, students may continue into PhD research programs within UCD’s School of Biomolecular and Biomedical Science or pursue advanced doctoral studies in bioprocessing, regulatory science, or biotechnology commercialization. This pathway allows graduates to deepen their expertise and prepare for leadership roles in academia, research, or industry innovation.